Drug intelligence / Profile preview

6-carbamimidoyl-2-[2-hydroxy-6-(4-hydroxy-phenyl)-indan-1-yl]-hexanoic acid

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule with the chemical formula C22H26N2O4 and a molecular weight of approximately 382.5 g/mol[1][7][8]. It is known by the code name GR166081 and DrugBank identifier DB06865[3][9]. The structure features an indan core substituted with hydroxy and hydroxyphenyl groups as well as a hexanoic acid side chain bearing a carbamimidoyl group. It has been categorized chemically as an amidine, amino fatty acid, aromatic homopolycyclic compound, carboxylic acid derivative, among others[2]. There is no evidence that this compound has reached clinical development or approval; it appears to be experimental with no marketed indications or established mechanism of action in humans[8][9].

Other names
6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID(2R)-6-carbamimidoyl-2-( (1S,2S)-2-hydroxy-6-(4-hydroxyphenyl)-2,3-dihydro -1H -inden -1 -yl )hexanoic acid(2R)-6-carbamimidoyl–2–[(1S, 2S)–2–hydroxy–6–(4-hydroxyphenyl)– 2,3-dihydro –1H –inden –1 –yl ]hexanoic acidGR166081GR-166081GR 166081
02

Targets

HDC (L-histidine decarboxylase)

Beyond the preview

Go deeper on 6-carbamimidoyl-2-[2-hydroxy-6-(4-hydroxy-phenyl)-indan-1-yl]-hexanoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 6-carbamimidoyl-2-[2-hydroxy-6-(4-hydroxy-phenyl)-indan-1-yl]-hexanoic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call